DE1055541B - Process for the preparation of beta-dialkylaminoacylanilides - Google Patents
Process for the preparation of beta-dialkylaminoacylanilidesInfo
- Publication number
- DE1055541B DE1055541B DEG18280A DEG0018280A DE1055541B DE 1055541 B DE1055541 B DE 1055541B DE G18280 A DEG18280 A DE G18280A DE G0018280 A DEG0018280 A DE G0018280A DE 1055541 B DE1055541 B DE 1055541B
- Authority
- DE
- Germany
- Prior art keywords
- group
- dialkylaminoacylanilides
- preparation
- piperidino
- phenyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 229910000761 Aluminium amalgam Inorganic materials 0.000 claims description 6
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 239000004215 Carbon black (E152) Substances 0.000 claims 1
- 229930195733 hydrocarbon Natural products 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 150000003931 anilides Chemical class 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 235000010624 Medicago sativa Nutrition 0.000 description 2
- 240000004658 Medicago sativa Species 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- XNOXXVVRXPFQCZ-UHFFFAOYSA-N 3-oxobutanoyl 3-oxobutanoate Chemical compound CC(=O)CC(=O)OC(=O)CC(C)=O XNOXXVVRXPFQCZ-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- VYNSHTVZDUPYBC-UHFFFAOYSA-N N-phenyl-3-piperidin-1-ylbutanamide Chemical compound C1CCCCN1C(C)CC(=O)NC1=CC=CC=C1 VYNSHTVZDUPYBC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
Description
DEUTSCHESGERMAN
Die vorliegende Erfindung betrifft em Verfahren zur Herstellung von gegebenenfalls im Benzolrmg substituierten yS-Dialkylammo-acylanihdenThe present invention relates to a process for the preparation of substances which may be substituted in the benzene ring yS-Dialkylammo-acylanihden
Diese Verbindungen besitzen wertvolle pharmakologische Eigenschaften, unter anderem als Anästhetika, insbesondere fur die nervenblockierende Anästhesie, und sind zum Teil im Patent 949 235 beschriebenThese compounds have valuable pharmacological properties Properties, including as anesthetics, especially for nerve-blocking anesthesia, and are described in part in patent 949 235
Es wurde nun gefunden, daß es möglich ist, gegebenenfalls im Benzolrmg substituierte /3-Monoalkylammoacylamlide und /3-Piperidmo-acylanilide mit unsubstituierter Phenylgruppe durch Reduktion aus den entsprechenden Immoverbindungen bzw deren tautomeren Formen herzustellen Die /J-Alkylimmoacylanilide können nämlich auch als in 1,2-Stellung ungesättigte 2-Alkylammo-acylanihde angesehen werden Die entsprechenden Verbindungen mit /3-standiger Pipendmogruppe liegen naturgemäß nur m letzterer Form vorIt has now been found that it is possible, if necessary / 3-Monoalkylammoacylamlides substituted in the benzene ring and / 3-Piperidmo-acylanilide with unsubstituted Phenyl group by reduction from the corresponding Immo compounds or their tautomeric Forms to manufacture the / J-alkylimmoacylanilides can namely also as 2-alkylammo-acylanihde unsaturated in the 1,2-position The corresponding compounds with the / 3-position pipendmo group are located naturally only in the latter form
In den Ber d dtsch. ehern Ges , 27 (1892), S 771, und in den Annalen der Chemie, 439 (1924), S 213, ist die Herstellung von jS-Immo-buttersaureamlid oder des damit tautomeren ß-Ammo-crotonsaureanihds durch Umsetzung von Acetessigsaureanihd mit Ammen beschrieben Aus diesen Veröffentlichungen geht klar hervor, daß sich das Reaktionsprodukt außerordentlich leicht zersetzt und beim Sieden m wäßriger Losung oder schon beim Losen des Hydrochlonds in Wasser bei Zimmertemperatur rasch und quantitativ in das entsprechende Amm und das Acetessigsaureanihd zuruckverwandelt wirdIn the Ber dtsch. Ehern Ges, 27 (1892), S 771, and in the Annalen der Chemie, 439 (1924), p. 213, is the Production of jS-Immo-buttersaureamlid or the with it tautomeric ß-Ammo-crotonsaureanihds by reaction of Acetoessigsaureanihd with Ammen described from It is clear from these publications that the Reaction product decomposes extremely easily and when boiling m aqueous solution or even when dissolving of the hydrochloride in water at room temperature is quickly and quantitatively converted back into the corresponding Amm and the acetoacetic acid anhydride
Unter diesen Umstanden war es nicht vorherzusehen, daß es möglich sein wurde, Verbindungen der oben angegebenen Art mit befriedigender Ausbeute zu den entsprechenden gesattigten Monoalkylammo- bzw Piperidinoverbindungen zu reduzierenUnder these circumstances it was not foreseeable that it would be possible to make connections to the above specified type with satisfactory yield to the corresponding saturated monoalkylammo- or piperidino compounds to reduce
Tatsachlich haben bisher angestellte Versuche zur Durchfuhrung dieser Reduktion, beispielsweise durch Hydrierung, im allgemeinen sehr niedrige Ausbeuten ergeben Überraschenderweise wurde gefunden, daß es möglich ist, diese Reduktion bei Verwendung von AIummiumamalgam mit verhältnismäßig guter Ausbeute durchzufuhrenIn fact, attempts hitherto have been made to carry out this reduction, for example by Hydrogenation, in general, give very low yields. Surprisingly, it has been found that it this reduction is possible when using aluminum amalgam to be carried out with a relatively good yield
Die Erfindung betrifft daher ein Verfahren zur Herstellung von /5-Dialkylammoacylamliden der allgemeinen FormelThe invention therefore relates to a method of production of / 5-dialkylammoacylamlides of the general formula
R1-CH-CH2-CO-NH-RR 1 -CH-CH 2 -CO-NH-R
τ? pτ? p
worm R eine gegebenenfalls substituierte Phenylgruppe, R1 einen Kohlen wasserst off rest, ζ Β eine Alkylgruppe, R2 und R3 Alkylgruppen oder gemeinsam mit dem Stickstoffatom eine Piperidmogruppe bedeuten, wobei im letzteren Fall die Phenylgruppe nicht substituiert ist, bei welchem man entsprechende Immoacylanilide bzw derenworm R is an optionally substituted phenyl group, R 1 is a hydrocarbon residue, ζ Β is an alkyl group, R 2 and R 3 are alkyl groups or, together with the nitrogen atom, a piperidmo group, in the latter case the phenyl group is not substituted, in which one corresponding immoacylanilide or their
Verfahren zur Herstellung
von ß-DialkylammoacylanilidenMethod of manufacture
of ß-dialkylammoacylanilides
Anmelder:Applicant:
Ed. Geistlich Sohne A. G.Ed. Spiritual sons A. G.
fur chemische Industrie,for chemical industry,
Wolhusen, Luzern (Schweiz)Wolhusen, Lucerne (Switzerland)
Vertretei Di F Zumstem
und Dipl -Chem Dr rer nat E Assmann,Representation Di F Zumstem
and Dipl -Chem Dr rer nat E Assmann,
Patentanwälte,
München 2, Brauhausstr 4Patent attorneys,
Munich 2, Brauhausstr 4
Beanspi uchte Priorität
Großbritannien vom 1 November 1954Claimed priority
Great Britain from November 1, 1954
Emil Hofstetter, Wolhusen, Luzern (Schweiz),
ist als Erfinder genannt wordenEmil Hofstetter, Wolhusen, Lucerne (Switzerland),
has been named as the inventor
tautomere Formen mit Aluminiumamalgam reduziert und, falls R2 Wasserstoff ist, anschließend die Alkylgruppe R3 m an sich bekannter Weise einfuhrttautomeric forms are reduced with aluminum amalgam and, if R 2 is hydrogen, then the alkyl group R 3 m is introduced in a manner known per se
Es ist vorteilhaft, die Reduktion in einem organischen und vorzugsweise in einem alkoholischen Losungsmittel durchzufuhren Methanol wird als Losungsmittel bevorzugt Dabei ist es außerdem zweckmäßig, die Temperatur so niedrig wie möglich, vorzugsweise bei Zimmertemperatur, zu haltenIt is advantageous to do the reduction in an organic and preferably in an alcoholic solvent Methanol is the preferred solvent It is also useful to adjust the temperature as low as possible, preferably at room temperature, to keep
Die Reduktion erfordert bis zur Beendigung einige Zeit, wahrend welcher das Reaktionsgemisch vorzugsweise kontinuierlich gerührt oder geschüttelt wird, um em grundliches Vermischen zu sichern Nach Beendigung kann das in der Losungsmittelschicht befindliche Reduktionsprodukt abgetrennt, von dem Losungsmittel beispielsweise durch Eindampfen im Vakuum befreit und in beliebiger Weise weiter aufgearbeitet werden.The reduction takes some to complete Time during which the reaction mixture is preferred is continuously stirred or shaken to Ensure thorough mixing. After completion, the reduction product in the solvent layer can be used separated off, freed from the solvent, for example by evaporation in vacuo, and can be worked up in any way.
Als Substituenten m der Phenylgruppe der als Ausgangsstoffe verwendeten /3-Monoalkylimmo-acylamlide kommen beispielsweise Alkyl-, Alkoxy-, Nitro- und Aminogruppen und Halogene in Frage Die Alkylreste der Dialkylaminogruppe des Endprodukts sind vorzugsweise Methyl- oder AthylgruppenAs substituents m of the phenyl group as starting materials used / 3-monoalkylimmo-acylamlides For example, alkyl, alkoxy, nitro and amino groups and halogens come into consideration. The alkyl radicals the dialkylamino group of the final product are preferred Methyl or ethyl groups
Wenn der Substituent im Ring, z. B eine Nitrogruppe, selbst reduzierbar ist, kann er bei dem erfindungsgemaßen Verfahren selbstverständlich reduziert werdenWhen the substituent in the ring, e.g. B a nitro group, is itself reducible, it can in the inventive Procedures are of course reduced
VS ' . 2« ' 909 507/556 VS '. 2 '' 909 507/556
Beispiel 1
a) Herstellung von /J-Äthylamino-buttersäureanilidexample 1
a) Production of / J-ethylamino-butyric anilide
50 g /5-Äthylammo-crotonsäureanilid werden in 450 ecm Methanol gelöst und dann mit 40 g des, wie unten beschrieben, hergestellten Aluminiumamalgams versetzt. Die Mischung wird 35 Stunden bei Zimmertemperatur gerührt. Die methanolische Lösung wird abgetrennt, filtriert und das Methanol im Vakuum verdampft.' Es hinterbleibt ein viskoses Öl, /J-Äthylamino-buttersäureanilid. Ausbeute 40 g (70,9% der Theorie).50 g / 5-ethylammocrotonic acid anilide are used in Dissolved 450 ecm of methanol and then mixed with 40 g of the aluminum amalgam prepared as described below. The mixture is stirred for 35 hours at room temperature. The methanolic solution is separated off, filtered and the methanol evaporated in vacuo. ' A viscous oil remains, / I-ethylamino-butyric anilide. Yield 40 g (70.9% of theory).
Das hier verwendete Aluminiumamalgam wird aus Aluminiumspänen, die zweimal mit n/10-Natronlauge, einmal mit Wasser, zweimal mit einer l°/oigen Lösung von Quecksilber(II)-chlorid und noch einmal mit Wasser gewaschen werden, frisch bereitet.The aluminum amalgam as used herein, is freshly prepared from aluminum shavings, once, twice with N / 10 sodium hydroxide solution, with water, twice with a liter ° / o solution of mercury (II) chloride and washed once with water.
b) Herstellung von /3-Diäthylam.ino-buttersäureanilidb) Production of /3-Diäthylam.ino-butyeanilid
70 g ß-Äthylamino-buttersäureanilid werden in 40 g Äthylbromid und 10 ecm Alkohol gelöst und während 72 Stunden gekocht. Danach wird die Reaktionsmasse in überschüssiger 2n-Salzsäure gelöst, filtriert und alkalisch gestellt. Die ausgefallene Substanz wird in Äther aufgenommen und gut getrocknet. In die trockene Ätherlösung wird trockener Chlorwasserstoff eingeleitet, wobei das Hydrochlorid von ß-Diäthylamino-buttersäureanilioUi ausfällt. Es schmilzt bei 132 bis 134° C und ist in Wasser gut löslich.70 g of ß-ethylamino-butyric anilide are used in 40 g of ethyl bromide and 10 ecm of alcohol dissolved and boiled for 72 hours. Then the reaction mass in Dissolved excess 2N hydrochloric acid, filtered and made alkaline. The precipitated substance is taken up in ether and dried well. Dry hydrogen chloride is passed into the dry ether solution, whereby the hydrochloride of ß-diethylamino-butyric acid anilioUi fails. It melts at 132 to 134 ° C and is easily soluble in water.
3030th
10 g ß-Piperidino-crotonsäureanilid werden in 250 ecm
Äther und 250 ecm Alkohol (90°/0ig) gelöst und mit 10 g Aluminiumamalgam versetzt. Nach 30- bis 40stündigem
Rühren bei Zimmertemperatur wird der Niederschlag abgetrennt und die klare Lösung eingeengt. Der
Rückstand wird in Essigester gelöst, und es wird Chlorwasserstoff eingeleitet, wobei das Hydrochlorid des
/3-Piperidinobuttersäureanilids ausfällt.
Ausbeute 5 g (43°/0). F. 209 bis 212°C.10 g of ß-piperidino-crotonic acid anilide are dissolved in 250 ecm of ether and 250 ecm of alcohol (90 ° / 0 ig) and mixed with 10 g of aluminum amalgam. After stirring for 30 to 40 hours at room temperature, the precipitate is separated off and the clear solution is concentrated. The residue is dissolved in ethyl acetate and hydrogen chloride is passed in, the hydrochloride of 3-piperidinobutyric anilide precipitating out.
Yield 5 g (43 ° / 0 ). M.p. 209 to 212 ° C.
Claims (3)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1055541X | 1954-11-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1055541B true DE1055541B (en) | 1959-04-23 |
Family
ID=10870930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DEG18280A Pending DE1055541B (en) | 1954-11-01 | 1955-10-29 | Process for the preparation of beta-dialkylaminoacylanilides |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE1055541B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2400540A1 (en) * | 1973-01-08 | 1974-08-15 | Astra Pharma Prod | PRIMAERAMINOACYLANILIDES, METHOD OF MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THEY |
-
1955
- 1955-10-29 DE DEG18280A patent/DE1055541B/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2400540A1 (en) * | 1973-01-08 | 1974-08-15 | Astra Pharma Prod | PRIMAERAMINOACYLANILIDES, METHOD OF MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THEY |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2429562A1 (en) | BENZOXAZOLINONE DERIVATIVES | |
| DE1919420A1 (en) | Process for the preparation of 2-mercaptobenzothiazole | |
| DE1912941C3 (en) | 1-phenyl ^ -amino-e-methoxypyridazinium salts | |
| DE1055541B (en) | Process for the preparation of beta-dialkylaminoacylanilides | |
| DE2855279C2 (en) | Chelated 1,8-naphthyridine derivative, process for its preparation and process for preparing 1,8-naphthyridine derivatives | |
| DE1232577B (en) | Process for the preparation of delta 4,9-3-oxo-11beta-hydroperoxy-19-nor-steroids | |
| DE955591C (en) | Process for the preparation of 2-methyl-4-cyclohexyl-6-dimethylaminomethylphenol | |
| DE941193C (en) | Process for the production of new, bisquaterner phosphonium compounds | |
| DE1110651B (en) | Process for the preparation of diaza-phenthiazines | |
| DE1545672A1 (en) | Dicarboximide derivatives and processes for their preparation | |
| DE577921C (en) | Process for the preparation of derivatives of ª ‰, ª ‰ -dialkylated or -alkylarylated acrylic acids | |
| DE637260C (en) | Process for the preparation of pyrazolone capsules | |
| DE1643784C (en) | Biologically active isothiocyanates and processes for their preparation | |
| DE1570032C (en) | Sulphonylureas, process for their preparation and drug excretion from 1214675 | |
| AT230882B (en) | Process for the production of 6-aminochryses | |
| DE1141995B (en) | Process for the preparation of derivatives of 4-oxycoumarin | |
| AT204043B (en) | Process for the preparation of the new 1-hydrazino-4- (pyridyl-methyl) -phthalazines and their salts | |
| DE650431C (en) | Process for the preparation of trisubstituted barbituric acids | |
| AT167275B (en) | Process for the preparation of sulfonamides of the thiazole series | |
| DE2236005C3 (en) | Dibenzagonal bracket on d, square bracket for -dioxepin- square bracket for 1.3 square bracket for -derivatives and their pharmacologically acceptable salts, as well as processes for their production and pharmaceuticals containing them | |
| DE2311185A1 (en) | METHOD FOR MANUFACTURING PHTHALAZONE | |
| CH414639A (en) | Process for the preparation of new heterocyclic compounds | |
| CH655930A5 (en) | METHOD FOR PRODUCING 3-HYDROXYBENZEDIAZEPINONES. | |
| DE2101813B2 (en) | New 17alpha- (2,3-difluoromethylene-prop-1'-en-1'-yl) -östra-4-en-3-ones, processes for their preparation and agents containing them | |
| CH421090A (en) | Process for the preparation of new N'-substituted N-arylsulfonylureas |